GCT-43. GAIN OF SHORT ARM OF CHROMOSOME 12 IS A MOLECULAR MARKER TO PREDICT PROGNOSIS AND REPRESENTS AN EARLY EVENT IN TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMORS

Kaishi Satomi, Hirokazu Takami, Shintaro Fukushima, Yoichi Nakazato, Shota Tanaka, Nobuhito Saito, Masayuki Kanamori, Toshihiro Kumabe, Keiichi Kobayashi, Motoo Nagane, Toshihiko Iuchi, Koji Yoshimoto, Masahiro Mizoguchi, Kaoru Tamura, Taketoshi Maehara, Keiichi Sakai, Kazuhiko Sugiyama, Kiyotaka Yokogami, Hideo Takeshima, Masahiro Nonaka, Akio Asai, Ryo Nishikawa, Masao Matsutani, Koichi IchimuraNeuro-Oncology 2020 · DOI

Abstract

Abstract Gain of short arm of chromosome 12 (12p) is commonly observed in testicular germ cell tumors (tGCTs) and also seen in intracranial GCTs (iGCTs). However, little is known about the clinical significance of 12p gain in iGCTs. We have collected over 200 fresh frozen tissue samples of iGCTs through the Intracranial Germ Cell Tumor Genome Analysis Consortium in Japan. Firstly, we analyzed DNA methylation profile in 83 iGCTs, 3 tGCTs (seminomas) and 6 normal control samples using Infinium Human Methylation 450K BeadChip array (Illumina, CA, USA) in order to determine 12p gain status. Then, fluorescence in situ hybridization (FISH) study was carried out on 3 mixed iGCT cases using 12p/CEP12 probe (Abbott Molecular, Abbott park, IL, USA). Lastly, 58 iGCTs with clinicopathological information were analyzed for progression-free survival (PFS) and overall survival (OS). Gain of 12p was observed in 100% (3/3) of seminoma, 14% (3/22) of germinoma, 17% (1/6) of mature teratoma, 25% (1/4) of immature teratoma, 55% (11/20) of mixed germ cell tumor, 100% (4/4) of yolk sac tumor, 100% (1/1) of embryonal carcinoma, and 100% (1/1) of choriocarcinoma. In total, 45% (37/83) of iGCT showed 12p gain. Different histological components in each mixed GCT shared the same 12p copy number status within each mixed GCT case. Both PFS and OS were significantly worse in iGCTs with 12p gain (PFS: P=0.027, OS: P=0.0012). Gain of 12p can be a molecular marker to predict prognosis and represents an early event in tumorigenesis prior to histological differentiation in iGCTs.
BibTeX
@inproceedings{satomi2020gct,
  author = {Kaishi Satomi and Hirokazu Takami and Shintaro Fukushima and Yoichi Nakazato and Shota Tanaka and Nobuhito Saito and Masayuki Kanamori and Toshihiro Kumabe and Keiichi Kobayashi and Motoo Nagane and Toshihiko Iuchi and Koji Yoshimoto and Masahiro Mizoguchi and Kaoru Tamura and Taketoshi Maehara and Keiichi Sakai and Kazuhiko Sugiyama and Kiyotaka Yokogami and Hideo Takeshima and Masahiro Nonaka and Akio Asai and Ryo Nishikawa and Masao Matsutani and Koichi Ichimura},
  title = {{GCT-43. GAIN OF SHORT ARM OF CHROMOSOME 12 IS A MOLECULAR MARKER TO PREDICT PROGNOSIS AND REPRESENTS AN EARLY EVENT IN TUMORIGENESIS IN INTRACRANIAL GERM CELL TUMORS}},
  booktitle = {Neuro-Oncology},
  year = {2020},
  doi = {10.1093/neuonc/noaa222.261},
}

Loading related content...

Figure